Girish N. Vyas

Girish N. Vyas's AcademicInfluence.com Rankings

Girish N. Vyas

Philosophy

#9686

World Rank

#13281

Historical Rank

Logic

#6655

World Rank

#8192

Historical Rank

philosophy Degrees

Girish N. Vyas

Biology

#13342

World Rank

#16887

Historical Rank

Virology

#328

World Rank

#335

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Girish N. Vyas's Degrees

Doctorate Medicine University of California, San Francisco
PhD Virology University of California, San Francisco

Why Is Girish N. Vyas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Girish N. Vyas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Viral hepatitis and liver disease (1984) (1405)
Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis (1970) (455)
Biology of hepatitis B virus. (1981) (346)
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. (1981) (340)
Anaphylactoid transfusion reactions associated with anti-IgA. (1968) (262)
Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. (1985) (257)
Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. (1987) (245)
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. (1978) (227)
The molecular biology of hepatitis B virus. (1989) (201)
A new rapid method for genetic typing of human immunoglobulins. (1968) (168)
Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. (1991) (164)
Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. (1974) (163)
Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. (1990) (163)
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. (1983) (160)
Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. (1989) (121)
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. (1982) (114)
Australia Antigen (Hepatitis B Antigen): A Conformational Antigen Dependent on Disulfide Bonds (1972) (100)
MOLECULAR PATHOGENESIS OF HEPATITIS B VIRUS INFECTION: SIMULTANEOUS DETECTION OF VIRAL DNA AND ANTIGENS IN PARAFFIN-EMBEDDED LIVER SECTIONS (1984) (100)
Serologic specificity of hun anti-IgA and its significance in transfusion. (1969) (92)
Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. (1989) (90)
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. (1977) (84)
Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. (1975) (82)
Molecular characterization of a new variant of hepatitis b virus in a persistently infected homosexual man (1990) (76)
Hepatitis B Viral Nucleotide Sequences in Non‐A, Non‐B or Hepatitis B Virus‐Related Chronic Liver Disease (1984) (69)
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. (1975) (69)
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. (1984) (65)
Am(1), the first genetic marker of human immunoglobulin A. (1969) (63)
Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. (1978) (56)
Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. (1972) (54)
A precore‐defective mutant of hepatitis B virus associated with e antigen‐negative chronic liver disease (1990) (54)
Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. (1989) (52)
Human antibodies to human IgA globulins. (1968) (52)
Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. (1989) (46)
Reduction of human immunodeficiency virus‐ infected cells from donor blood by leukocyte filtration (1989) (45)
Isoimmune anti-IgA causing anaphylactoid transfusion reactions. (1969) (45)
Transfusion medicine and safety. (2009) (45)
Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects (1988) (42)
Preparation and use of therapeutic antibodies primarily of human origin. (2008) (42)
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors (1993) (42)
Immune response to hepatitis B surface antigen (1975) (39)
Lmmunobiology of human anti‐lgA: a serologic and immunogenetic study of immunization to IgA in transfusion and pregnancy * (1970) (38)
Characterization of the interaction between polymerized human albumin and hepatitis B surface antigen. (1981) (37)
Hepatitis B immune globulin preparations and use in liver transplantation. (2003) (36)
An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. (1993) (34)
Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. (1981) (33)
Intrauterine Isoimmunization caused by Maternal IgA crossing the Placenta (1970) (32)
A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. (1979) (32)
Study of blood groups, abnormal hemoglobins and other genetical characters in some tribes of Gujarat. (1962) (31)
Eradicating hepatitis B virus: The critical role of preventing perinatal transmission. (2017) (31)
A lack of direct role of hepatitis B virus in the activation of ras and c‐myc oncogenes in human hepatocellular carcinogenesis (1988) (31)
T-cell dependence of immune response to hepatitis B antigen in mice (1975) (31)
A new virus specified determinant of hepatitis B surface antigen. (2009) (29)
Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood. (1982) (27)
Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5. (1977) (27)
Hepatitis B virus infection. Current concepts of chronicity and immunity. (1984) (25)
Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11-dUTP. (1993) (25)
Human antibodies to ruminant IgM concealing the absence of IgA in man. (1971) (25)
Viral hepatitis : a contemporary assessment of etiology, epidemiology, pathogenesis, and prevention : proceedings of the Second Symposium on Viral Hepatitis, University of California, San Francisco, March 16-19, 1978 (1978) (24)
Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. (1990) (23)
Resolution of infection status of human immunodeficiency virus (HIV)‐ seroindeterminate donors and high‐risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high‐prevalence area (1992) (22)
Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. (1989) (22)
Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. (1990) (22)
Hepatitis B Antigen Activity in Protein Subunits produced by Sonication (1973) (21)
Hepatitis B virions isolated with antibodies to the pre‐S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted (2000) (21)
Transfusion-related transmissible diseases: detection by polymerase chain reaction-amplified genes of the microbial agents. (1994) (19)
In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. (1987) (19)
Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. (1991) (19)
Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin- or fluorescein-labeled dUTP. (1995) (18)
Correlation of the hepatitis B surface and e antigens. (1978) (18)
Passive haemagglutination test for anti-rhinovirus antibodies. (1971) (17)
Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. (1974) (16)
In vitro inactivation of human immunodeficiency virus by ascorbic acid. (1995) (15)
Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes (1994) (15)
Laboratory diagnosis of hepatitis B virus infection by nucleic acid hybridization analyses and immunohistologic detection of gene products. (1985) (15)
Three Cases of Weak B in an Indian Family (1960) (14)
Complement Killing of Yersinia enterocolitica and Retention of the Bacteria by Leucocyte Removal Filters (1994) (14)
Eleven Cases of “Bombay” Phenotype in Six Families: Suppression of ABO Antigen Demonstrated in Two Families (1961) (13)
HEPATITIS B VIRUS IN NON-HEPATOCYTES (1983) (13)
Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase (1994) (13)
Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors (1987) (13)
Experimental Study of Aldomet‐Induced Positive Antiglobulin Reaction. I (1969) (13)
Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus. (1991) (13)
Letter: Nonspecificity of hepatitis B antigen detected with iodine-125-labeled antibody. (1973) (12)
Radioimmunoassay of Hepatitis B Core Antigen and Antibody with Autologous Reagents 1 (1977) (12)
Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. binding of polyalbumin to Clq (1981) (12)
Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. (1986) (12)
Isoantibodies to human IgM: serologic and immunochemical investigations. (1971) (12)
Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: II. involvement of Clq in or near the hepatitis B surface antigen receptor for polyalbumin (1981) (11)
Transmission of HIV-1 in infants born to seropositive mothers: PCR-amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads. (1997) (11)
Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. (1988) (11)
DNA enzyme immunoassay of the PCR-amplified HLA-DQ alpha gene for estimating residual leukocytes in filtered blood (1995) (10)
Quinacetophenone Monomethyl Ether (2003) (10)
Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N). (2000) (9)
Immunodiagnosis of viral hepatitides A to E and non-A to -E (1996) (9)
Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection. (1990) (9)
A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate. (2007) (8)
Comparison of Counterelectrophoresis and Hemagglutination Inhibition Tests for Hepatitis‐Associated Antigen 1 (1972) (8)
Hepatitis B surface antigen (HBs Ag): tryptophan content and biological activity. (1974) (7)
Antibodies to IGA in Pregnancy and in Recipient of Rho(D) Immune Globulin (Human) (1972) (7)
Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay. (1977) (6)
A Simple Inexpensive Method for Demonstrating in vitro Leukocyte Migration 1 (1973) (6)
Hepatitis B Virus (1999) (6)
Study of a French family with a new variant of blood group A: A lae . (1972) (5)
Yeast recombinant hepatitis B vaccine in perinatal hepatitis B virus transmission: a preliminary report. (1986) (5)
In vitro Transfer of Cell-mediated Immunity to Hepatitis B Antigen with RNA (1974) (5)
Human peripheral blood mononuclear cell substrate for propagating wild type HIV-1. (2001) (5)
Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection (2011) (5)
Tolerance to hepatitis B antigen: a hypothesis for its termination with 'immune-RNA'. (1974) (5)
Neutralizing antibodies against HIV determined by amplification of viral long terminal repeat sequences from cells infected in vitro by nonneutralized virions. (1998) (5)
Detection and Elimination of Blood-Borne Viruses Transmitted by Transfusion (1991) (4)
Letter: Hepatitis in selective IgA deficiency? (1975) (4)
Non-A, non-B hepatitis: a contemporary assessment. (1982) (4)
Magnesium-mediated reversal of the apparent virucidal effect of ascorbic acid or congo red reacted in vitro with the human immunodeficiency virus. (1996) (4)
Structure and activity of hepatitis B antigen (HBAg). 1. Studies on some conformational aspects and chemical modification of hepatitis B antigen. (1974) (4)
Detection of exceedingly low levels of HIV proviral DNA in multimillion peripheral blood mononuclear cells by PCR. (1993) (4)
Participating in the evolution of transfusion medicine from a dispensary into a discipline. (2008) (4)
Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion (1989) (4)
The role of the hepatitis B virus infection in patients with chronic hepatitis in argentina (1978) (4)
Use of B. Subtilis Neutral Proteinase in Blood Group Serology 1 (1968) (4)
Evolutionary Dissociation of γG2 and Gm(n) Antigens 1 (1969) (4)
Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. (2012) (4)
Diagnosis of viral hepatitis. (1987) (4)
RED CELL, PLASMA AND BLOOD VOLUME MEASURED BY RADIOCHROMIUM LABELLED CELLS AND HAEMATOCRIT IN INDIANS BELONGING TO LOW AND HIGH SOCIO-ECONOMIC GROUPS. (1965) (3)
Immunologic mechanisms in hepatitis B assayed by antigen-binding lymphocytes. (1975) (3)
Guest Editorial: Symposium on Transfusion-Associated Infections and Immune Response (1988) (3)
Further Evaluation of a Latex Agglutination Test for Detection of Hepatitis B Antigen (1974) (3)
Hepatitis B immune globulin (1978) (3)
Appraisal and prospects of a dimeric synthetic peptide coupled with tetanus toxoid for a bifunctional vaccine against hepatitis B virus infection. (1983) (3)
Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors (1988) (3)
Hepatitis C virus detection in blood donors (1991) (3)
Nonspecific test reaction for antibodies to hepatitis B surface antigen in chronic HBAg carriers. (1977) (3)
Anti‐IgA in Blood Donors (2003) (3)
HUMAN ANTIBODIES TO HUMAN IgA: A CLINICAL, SEROLOGIC AND IMMUNOGENETIC STUDY (1971) (3)
Blood-borne Infections Associated with Transfusion (1992) (3)
Biochemical characterization of hepatitis B surface antigen in relation to serologic activity. (1976) (2)
Recovery of Hepatitis B Antibody from Human Plasma Products Separated by a Modified Cohn Fractionation (1974) (2)
Laboratory diagnosis of viral hepatitis. (1983) (2)
Immunobiology of persistent blood-borne viral infections. (2000) (2)
A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes. (1986) (2)
Hepatitis B antigen and antibodies: detection by hemagglutination assay. (1972) (2)
Hemagglutinating substances in plant seeds. (1967) (1)
Internal medicine-epitomes of progress: immunodiagnosis of viral hepatitis. (1980) (1)
Blood-transmitted prions and variant Creutzfeldt-Jakob disease. (2007) (1)
Chalkones from quinacetophenone monomethyl ether. (1950) (1)
Structure and activity of hepatitis B antigen (HBAg). 2. Amino acid composition of an active subunit of HBAg. (1974) (1)
Studies in Potential Antimycobacterial Agents: Part IV Synthesis of p -Alkylamino -amino-o -Hydroxydiphenyl Sulfones (1954) (1)
Comparative data on the detection of hepatitis-B surface antigen by six centres. (1981) (1)
Possible transmission of human immunodeficiency virus-1 infection from an elite controller to a patient who progressed to acquired immunodeficiency syndrome: a case report (2012) (1)
Synthesis of Some Potential Antimycobacterial Agents (1952) (0)
Symposium on transfusion-associated infections and immune response. (1988) (0)
Clinical and Immunological Study of Human Anti-IgA (1972) (0)
Nonhemolytic Reactions to Blood Transfusion and Organ Transplantation1 (1972) (0)
Studies in potential antimycobacterial agents: part XIV- synthesis of p-alkylamino-p'-amino-o, m and m'- methoxy and hydroxy and m, m'- dimethoxy and hydroxydiphenyl sulfones (1958) (0)
Avant-garde biologicals (2006) (0)
[Effective use of hepatitis tests]. (1990) (0)
digoxigenin-11- dUTP analyses of polymerase chain reaction-amplified DNA incorporating Detection of hepatitis B virus in plasma using flow cytometric (2011) (0)
United States Patent ( 19 ) Vyas 54 SAFE VACCINE FOR HEPATITIS CONTAINING POLYMERIZED SERUM (2017) (0)
Letter: Anti-IgA in blood donors. (1976) (0)
IN VITRO NEUTRALIZATION OF HIV-1 USING PCR-AMPLIFICATION OF THE LTR SEQUENCES: POTENTIAL UTILITY OF THIS RAPID ASSAY IN ASSESSING THE EFFICACY OF VACC INATION (1996) (0)
Molecular Immunology of Viral Antigens in Hepatitis B Vaccination (1989) (0)
Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusions. (1988) (0)
Partial amino acid sequence of two major component polypeptides of hepatitis (0)
Hepatitis-B immune globulin (2017) (0)
Other virus infections in AIDS. IV. AIDS and hepatitis B virus infection. (1989) (0)
Biology of hepatitis delta virus. (1988) (0)
Advances in transfusion safety. San Francisco, CA, USA, March 18-20, 1999. (2000) (0)
Specific immunotherapy proposed for hepatitis B virus infection. (1975) (0)
Editorial summary of the Pre-symposium workshop on the Contemporary Assessment of Technologies. (1996) (0)
Flavonols: Direct new synthesis of 6-hydroxy-flavonols (1950) (0)
Axx, a New Variant of Blood Group A (1972) (0)
Flavones: A direct synthesis of 6-hydroxy-flavones (1951) (0)
HIV-Env protein subunits containing native gp41 and gp120 in immunoreactive form are enriched by DC-SIGN lipoparticles. (113.22) (2012) (0)
HIV-infected cells and DNA amplification Evaluation of leukocyte removal filters modelled by use of (2011) (0)
The risk of HIV transmission by screened blood. (1996) (0)
Hepatitis B antigen activity in protein subunits produced by sonicaation. (1973) (0)
Current Concepts of Chronicity and Immunity (0)
A CONTEMPORARY ASSESSMENT OF THE GENETIC CONTROL OF HUMAN IGA DEFICIENCY (1996) (0)
Molecular approaches to the detection of agents in persistent viral infections. (1993) (0)
Hepatitis B Virus and Hepatocellular Carcinoma (1986) (0)
Plasmapheresis of hepatitis B surface antigen carriers. (1980) (0)
Studies in penicillin salts. III. Stability of N, N'-dialkylethylenediamine penicillin G. (1959) (0)
The life and legacy of Alfred M. Prince, M. D. (1928-2011). (2012) (0)
Remembering James W. Mosley, MD (1929-2015), and his legacy in transfusion safety. (2016) (0)
Suppression of gene A in two cases of anti-H (Bombay bloods) in a family from South Canara. (1962) (0)
and non-A to -E. Immunodiagnosis of viral hepatitides A to E (2013) (0)
Hepatitis and blood transfusion : proceedings (1972) (0)

This paper list is powered by the following services:

Girish N. Vyas's Academic­Influence.com Rankings

Girish N. Vyas's Degrees

Why Is Girish N. Vyas Influential?

Girish N. Vyas's Published Works

Published Works

Girish N. Vyas's AcademicInfluence.com Rankings